Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SUMMARY LXGTF : Lexington BioSciences (CSE: LNB) (OTCQB: LXGTF) is developing
the HeartSentry, a new non-invasive diagnostic tool for accurately measuring
and monitoring cardiovascular health.
• The HeartSentry measures the function of the endothelium – the critical inner
lining of a person’s cardiovascular system.
• The core research and IP portfolio has been exclusively licensed to the
company.
• Lexington is in final stages of releasing the product into clinical studies for FDA
approval.
• The cardiovascular diagnostic market is growing fast and evolving into
personalized medicine.
• The goal is to make HeartSentry the standard of care for cardiologists, general
practitioners, and ultimately patients first line evaluation of cardiovascular
health.
• We seek the participation of dedicated stakeholders and committed
partners who share our vision of the future of cardiovascular personalized
medicine.
green +2,7% love it!
SOME DD LINKS and info "Las Vegas, NV (FSCwire) - Adama Technologies Corp. (OTCPINK:ADAC) announced today their plans to expand their online retail space to include a broader range of products in addition to the high end, big ticket items already being considered. The online retail store called CryX ( www.CryX.shop ) will also feature an option where customers can purchase products at a discount if they use the CryX coin. Adama Technologies has added a special preview option so investors can see the progress on the launch, which is planned for early 2018. The preview is located at, www.CryX.shop/preview.html .
that's crazy
Good materials, amazing team
Hi Italian, good to see you :)
ABOUNDANCE IS HERE: Multi-Billion Dollar Global Medical Device Industry Led By Cardiovascular Monitoring Devices
Global revenues for the medical device market are already a multi-billion dollar industry and the sector aims to continue its growth through leverage created through mergers and acquisitions, as well as the development of new products with improved efficiency. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as spine disorders, diabetes, and cardiovascular diseases, are expected to drive the market growth. In terms of application, the cardiovascular segment is expected to register the highest CAGR. The medical device sector as a whole has long been one of the more lucrative markets in the overall healthcare industry, as technology and research have propelled the market to new heights. With the rising influence of technology, the players in the medical device market are constantly diversifying and include some big tech names as of late. Active healthcare companies today with current developments include: Lexington Biosciences, Inc. (CNSX:LNB.CN) (OTC:LXGTF), Immunomedics Inc. (NASDAQ:IMMU), Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), BioTelemetry Inc. (NASDAQ:BEAT), VistaGen Therapeutics Inc. (NASDAQ:VTGN).
GREAT TEAM INVOLVED EVEN IN FUNDING
The principals, directors and advisors of Lexington
BioSciences have been individually and collectively
involved in raising extensive capital funding for their
private and public companies. Team members have held
numerous executive leadership positions encompassing
biotechnology, and medical device companies, as well as
multi-national corporations. The team includes inventors,
scientists, and business people who have successfully
started, built and grown multiple life science companies.
LXGTF simplify and save lifes! Current Standards are Complicated and Expensive!!!
• Gold standard - ULTRASOUND
• Measurement directly views arterial diameter
changes
• Only at specialized diagnostic centers
• Requires trained ultrasonographer
• Expensive capital equipment needed
• Alternative method - ENDOPAT
• Measurement uses a fingertip blood oxygen
sensor and laptop computer.
• Only at specialized diagnostic centers
• Requires trained technician
Currently only used in specialized research centers by highly trained staff
The FACTS ARE: Undiagnosed Cardiovascular Disease Is a Killer
• 1 in 3 deaths annually are caused by heart disease
and stroke.
• 1.5 million people suffer heart attacks annually in
the U.S.
• Nearly 1/3 of the deaths could be prevented
through proactive changes in lifestyle habits.
• Often the FIRST SYMPTOM of coronary artery
disease is a heart attack.
EARLY DETECTION OF THE PROBLEM IS ESSENTIAL
The only way to detect that arteries are vulnerable to
atherosclerosis is to assess endothelial function. This is a
test of the endothelial cells that line all the arteries in the body.
The endothelium is the single layer of cells that line various
organs and cavities, especially the heart, blood and lymphatic
vessels. These cells act as a shield, preventing plaque from
forming inside the artery wall, and produce substances that
stop blood clots from developing in the vessel.
Healthy endothelial cells release nitric oxide (NO), which
is responsible for most of the protective functions of these
cells in the artery.
In an at-risk individual, the endothelial cells do not
produce enough NO, or the NO produced is deactivated
by chemicals in the bloodstream before it can prevent
deposits from forming in the arterial wall.
today we can see a breakout after all the preparations, good time to make some decisions
Hello everybody :)
True, in today world many genuine things starting to have negative conotations because of the wrong usage but here we don't have fake news but real gems :)
To have the feeling baaam buuum bang happy new yeeear!! :)
Impresssive data
I like to watch my preferit players winning, what to say
LXGTF have good promo materials
Is nice to whatch it in holiday atmosphere
Tmrw we can expect a great exiting day in my oppinion
Haha who knows
Revolution is the right word Blockchain
Wow I think we can definitely expect something good this week
Come on!
LXGTF have no rivals
Right, the company is a team of unusual professionals in the field
ADAC is green + 25
ADAC is green + 25 NOW
This is a great breaking news
Wow what's that +25 green dream?
Looking for a great day again
GOOD ARTICLE RECENTLY RELEASED
https://insiderfinancial.com/lexington-bioscien-otcmktslxgtf-venturing-into-fortune-500-territory
MORE ABOUT NAVIGANT: Navigant Consulting is a specialized professional services firm based in Chicago, Illinois. The company has nearly 50 offices across the United States, Canada, Europe, Middle East and Asia. Navigant recently acquired Quorum Consulting, a San Francisco based specialist service provider with extensive experience in the field of medical device reimbursement and health economics. Services include a proven ability to define strategic business opportunities and of influencing global coverage and payment policies. For more information, visit: http://www.navigant.com .
LXGTF engages Diablo research for next step in FDA clearance..
https://finance.yahoo.com/news/lexington-biosciences-engages-clinical-research-140000876.html
LXGTF is potential 50 Billion Dollar Industry Penny Stock to Watch!
Read More here:
https://t.co/4nL5f2LtnQ
MOVING FORWARD MIGHTLY! Lexington Biosciences, Inc. (CNSX:LNB.CN) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to announce entry into a strategic business relationship with a San Francisco arm of Navigant Consulting Inc., formerly Quorum Consulting. The intent of the relationship is to work with the relevant authorities towards developing a coverage policy in support of the planned commercial rollout of Lexington's HeartSentry endothelial function measurement product. Read this and more news for Lexington Biosciences at:
http://www.marketnewsupdates.com/news/lxgtf.html
MUST WATCH! AMAZING LXGTF video: https://vimeo.com/183611304
NEW HERE? Check the LXGTF website: https://lexingtonbiosciences.com/